Get the Stockscreener App
17.25
0.72%
-0.16
Innoviva Inc stock is traded at $17.25, with a volume of 149.57K.
It is down -0.72% in the last 24 hours and down -5.13% over the past month.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
See More
Previous Close:
$17.41
Open:
$17.4
24h Volume:
149.57K
Relative Volume:
0.25
Market Cap:
$1.09B
Revenue:
$330.50M
Net Income/Loss:
$145.42M
P/E Ratio:
10.45
EPS:
1.65
Net Cash Flow:
$157.96M
1W Performance:
-1.73%
1M Performance:
-5.13%
6M Performance:
-12.75%
1Y Performance:
+17.19%
1-Day Range:
$17.20
$17.45
1-Week Range:
$17.20
$17.91
52-Week Range:
$14.32
$21.28
Innoviva Inc Stock (INVA) Company Profile
Name
Innoviva Inc
Sector
Industry
Phone
(650) 238-9600
Address
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Compare INVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
17.29 | 1.09B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.30 | 130.96B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
685.15 | 75.53B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
578.42 | 35.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
242.21 | 31.72B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
249.40 | 26.76B | 3.32B | -860.46M | -1.04B | -8.32 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jun-18-24 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-20-22 | Initiated | Goldman | Neutral |
| Nov-20-17 | Initiated | Deutsche Bank | Hold |
Innoviva Inc Stock (INVA) Latest News
Armata Pharmaceuticals Announces $10 Million Secured Credit Agreement with Innoviva - Longview News-Journal
(INVA) Investment Analysis and Advice - Stock Traders Daily
Innoviva (NASDAQ:INVA) Research Coverage Started at Scotiabank - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $2,665,215.25 in Stock - Defense World
Innoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $20,966,989.92 in Stock - Defense World
Innoviva (NASDAQ:INVA) Stock Rating Upgraded by StockNews.com - Defense World
Scotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform Recommendation - Nasdaq
Innoviva stock sees $28 million sale by Alexander J. Denner - Investing.com Australia
Innoviva to Participate in the Barclays 27th Annual Global Healthcare Conference - BioSpace
Innoviva CEO Fireside Chat: What Strategic Updates Await at Barclays Healthcare Conference? - StockTitan
Principal Financial Group Inc. Boosts Stock Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rhumbline Advisers Has $3.25 Million Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lowered by Denali Advisors LLC - MarketBeat
When the Price of (INVA) Talks, People Listen - Stock Traders Daily
Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results - MarketBeat
Innoviva (INVA) to Release Quarterly Earnings on Thursday - MarketBeat
Innoviva (INVA) to Release Earnings on Thursday - Defense World
Innoviva: Q4 Earnings Snapshot - Thehour.com
Innoviva, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2024 - Marketscreener.com
Innoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company Progress - BioSpace
Innoviva Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings Flash (INVA) INNOVIVA INC. Posts Q4 Revenue $91.8M, vs. FactSet Est of $86.8M - Marketscreener.com
Hussman Strategic Advisors Inc. Increases Stock Position in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
Allspring Global Investments Holdings LLC Cuts Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva: Underappreciated Strength In Hospital Therapeutics (NASDAQ:INVA) - Seeking Alpha
StockNews.com Downgrades Innoviva (NASDAQ:INVA) to Hold - Defense World
Innoviva, Inc. (NASDAQ:INVA) Short Interest Update - MarketBeat
Short Interest in Innoviva, Inc. (NASDAQ:INVA) Declines By 10.2% - Defense World
Entropy Technologies LP Invests $248,000 in Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
(INVA) Investment Analysis - Stock Traders Daily
Innoviva, Inc. (NASDAQ:INVA) Shares Acquired by Empowered Funds LLC - Defense World
Innoviva (NASDAQ:INVA) Lowered to Hold Rating by StockNews.com - Defense World
Innoviva (INVA) Shares Cross Below 200 DMA - Nasdaq
Innoviva (NASDAQ:INVA) Rating Increased to Buy at StockNews.com - MarketBeat
(INVA) Investment Report - Stock Traders Daily
Ratio Review: Analyzing Innoviva Inc (INVA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Innoviva to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference - Business Wire
Healthcare Watch: Innoviva's Strategic Vision Takes Center Stage at Major Oppenheimer Conference - StockTitan
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Pacer Advisors Inc. - MarketBeat
Franklin Resources Inc Reduces Stake in Innoviva Inc - GuruFocus.com
Brokers Set Expectations for Innoviva FY2025 Earnings - Defense World
Cantor Fitzgerald Comments on Innoviva FY2025 Earnings - MarketBeat
Innoviva (NASDAQ:INVA) investors are up 4.7% in the past week, but earnings have declined over the last five years - Simply Wall St
Innoviva Inc Stock (INVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Innoviva Inc Stock (INVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
5.68%
0.28%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):